These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 18780796
1. Medical therapy for clinically non-functioning pituitary adenomas. Colao A, Di Somma C, Pivonello R, Faggiano A, Lombardi G, Savastano S. Endocr Relat Cancer; 2008 Dec; 15(4):905-15. PubMed ID: 18780796 [Abstract] [Full Text] [Related]
2. Diagnosis and treatment of pituitary adenomas. Chanson P, Salenave S. Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032 [Abstract] [Full Text] [Related]
8. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence. Arnold JR, Arnold DF, Marland A, Karavitaki N, Wass JA. Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640 [Abstract] [Full Text] [Related]
15. Gonadotroph cell pituitary adenomas in males. Manieri C, Di Bisceglie C, Razzore P, Fornengo R, Papotti M, Isolato G, Ciccarelli E. Panminerva Med; 2000 Dec 07; 42(4):237-40. PubMed ID: 11294084 [Abstract] [Full Text] [Related]
16. Pituitary adenoma. Goldstein JE, Sherman JF. Optom Clin; 1993 Dec 07; 3(3):101-25. PubMed ID: 8199444 [Abstract] [Full Text] [Related]
17. Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Minniti G, Esposito V, Piccirilli M, Fratticci A, Santoro A, Jaffrain-Rea ML. Eur J Endocrinol; 2005 Dec 07; 153(6):723-35. PubMed ID: 16322376 [Abstract] [Full Text] [Related]
18. Pituitary adenomas: an overview. Lake MG, Krook LS, Cruz SV. Am Fam Physician; 2013 Sep 01; 88(5):319-27. PubMed ID: 24010395 [Abstract] [Full Text] [Related]
19. The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology. Ferone D, Gatto F, Arvigo M, Resmini E, Boschetti M, Teti C, Esposito D, Minuto F. J Mol Endocrinol; 2009 May 01; 42(5):361-70. PubMed ID: 19141603 [Abstract] [Full Text] [Related]
20. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro. Winczyk K, Kunert-Radek J, Gruszka A, Radek M, Ławnicka H, Pawlikowski M. Neuro Endocrinol Lett; 2009 Mar 01; 30(1):107-10. PubMed ID: 19300395 [Abstract] [Full Text] [Related] Page: [Next] [New Search]